Three of the CLL samples tested were derived from patients with known mutations in BIRC3, that are associated with NIK stabilization and consequent p100 processing resulting in the nuclear translocation of p52. The gene discussed is NFKB2; the disease is B-cell chronic lymphocytic leukemia.